Volume | 76,413 |
|
|||||
News | - | ||||||
Day High | 13.29 | Low High |
|||||
Day Low | 12.55 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Annovis Bio Inc | ANVS | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
12.55 | 12.55 | 13.29 | 12.74 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
670 | 76,413 | US$ 12.97 | US$ 991,431 | - | 5.42 - 22.49 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
10:38:07 | 15 | US$ 12.96 | USD |
Annovis Bio (ANVS) Options Flow Summary
Annovis Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
133.41M | 10.26M | - | 0 | -56.2M | -5.48 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Annovis Bio News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANVS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.11 | 13.6499 | 9.04 | 11.48 | 300,429 | 3.85 | 42.26% |
1 Month | 12.00 | 13.6499 | 8.86 | 11.24 | 207,853 | 0.96 | 8.00% |
3 Months | 11.64 | 13.6499 | 8.1001 | 10.61 | 223,910 | 1.32 | 11.34% |
6 Months | 7.94 | 22.49 | 5.42 | 11.36 | 261,130 | 5.02 | 63.22% |
1 Year | 14.81 | 22.49 | 5.42 | 11.40 | 147,711 | -1.85 | -12.49% |
3 Years | 23.70 | 132.00 | 5.42 | 44.03 | 255,589 | -10.74 | -45.32% |
5 Years | 9.10 | 132.00 | 2.418 | 33.71 | 260,757 | 3.86 | 42.42% |
Annovis Bio Description
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. |